Poland· PL-100198447
Mepidont 3%
A mepivacaine product containing mepivacaini hydrochloridum, registered in Poland by Molteni Dental s.r.l.. The same ATC class is registered in 18 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Mepivacaine is registered in 18 of 19 countries.
Countries holding a registration under ATC N01BB03 (mepivacaine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 10 of them publish a price we can compare per daily dose
Mepivacaine · ATC N01BB03
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Mepivacaini hydrochloridum
- Manufacturer
- Molteni Dental s.r.l.
- Country
- Poland (PL)
- ATC code
- N01BB03
- ATC class
- Mepivacaine
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990220328
- gtin05909990220311
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
24 interactions on record for mepivacaine.
Graded by severity as the source publishes them — 23 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Mepivacaine · interactions on record
24 records
- 23 moderate
- 1 minor
Most severe, free to view
- LidocainA01AE01moderate
- TetracainA01AE02moderate
- LidocaineC05AD01moderate
- TetracaineC05AD02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Mepivacaine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainISOGAINE 30 mg/ml SOLUCION INYECTABLELaboratorios Clarben S.A.
- FinlandMepidentalLaboratorios Inibsa S.A.
- BelgiumMepicart 30 mg/mlLaboratorios Inibsa
- CzechiaSCANDONESTSEPTODONT OU SEPTODONT SAS OU SPECIALITES SEPTODONT, Saint-Maur-des-Fosses
- NorwayCarbocain DentalDentsply DeTrey GmbH
- SwedenCarbocain dental 30 mg/ml Injektionsvätska, lösningDentsply DeTrey GmbH
- SwitzerlandScandonest 30 mg/ml, InjektionslösungSeptodont Switzerland GmbH
- IcelandCarbocain DentalDENTSPLY DeTrey GmbH*
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Mepinaest Purum, Scandonest Ohne Vasokonstriktor
- Belgium · Mepicart, Mepivastesin
- Bulgaria · Мепидентал, Скандонест
- Cyprus · Imeros, Mepidental
- Czechia · Scandonest
- Germany · Meaverin, Mecain
- Denmark · Carbocain, Mepidental
- Estonia · Scandivin, Scandonest
- Spain · Isogaine, Mepivacaína B. Braun
- Finland · Mepidental, Scandonest
- France · Carbocaine, Mepivacaine B. Braun
- United Kingdom (Northern Ireland) · Biocaine Plain, Mepivacaine Hydrochloride Accord Healthcare
- Greece · Imeros, Scandonest
- Croatia · Scandonest
- Hungary · Scandonest
- Ireland · Scandonest
- Iceland · Carbocain, Carbocain Dental
- Italy · Carbosen, Mepicain
- Lithuania · Mepivastesin, Scandivin
- Luxembourg · Mepicart, Scandicaïne
- Latvia · Scandivin, Scandonest
- Netherlands · Imeros, Mepicart
- Norway · Carbocain Dental, Scandonest Plain
- Portugal · Isogaine, Mepivacaína Braun
- Romania · Mepidental, Mepivacaina Normogen
- Sweden · Carbocain, Carbocain Dental
- Slovenia · Scandicaine
- Slovakia · Mepivastesin, Scandonest
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ccc7c000-d05d-488f-9041-43e5ef1810f3 GET /v1/drugs/ccc7c000-d05d-488f-9041-43e5ef1810f3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "30 mg/ml",
"packaging": "05909990220328 ¦ Rp ¦ 1375\n50 amp.-strzyk. 1,8 ml\n05909990220311 ¦ Rp ¦ 20880\n10 amp.-strzyk. 1,8 ml",
"substance": "Mepivacaini hydrochloridum 54 mg",
"common_name": "Mepivacaini hydrochloridum",
"pl_product_id": "100198447",
"pozwolenie_nr": "02203",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about mepivacaine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.